other material
confidence high
sentiment neutral
materiality 0.40
Corvus Pharmaceuticals suspends $100M ATM equity offering program
Corvus Pharmaceuticals, Inc.
- Suspended $100M at-the-market offering; zero shares sold prior to suspension.
- Company notified Jefferies; no sales until new prospectus supplement or registration statement filed.
- Sale Agreement remains in full force and effect despite suspension.
- Company cites proposed registered underwritten public offering as context.